Loading ...

PEI8.3-(C16-C18-EO25)1.4/siGL3 nanocomplex

Based on

1 Articles
2011 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(ethylene imine)-graft-poly(ethylene glycol) copolymer

PEI25-PEG(2)10 PEI-PEG
Type Polymer
Formula
Role carriers
2

siRNA against luciferase GL3

siGL3
Type Biomolecule
Formula
Role loaded material

Properties

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
female C57BL/6J-Tg(Bos/GFP)CaBa-Bii011Dcm mouse (lungs)

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • siRNA against luciferase GL3
  • poly(ethylene imine)-graft-poly(ethylene glycol) copolymer
  1. 4w29KvM84E0R
Product

PEI8.3-(C16-C18-EO25)1.4/siGL3 nanocomplex

Size: not specified

Medium: water

Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  • siRNA against luciferase GL3
  • poly(ethylene imine)
  1. PErADQtTbV9G
Product

PEI8.3-(C16-C18-EO25)1.4/siGL3 nanocomplex

Size: not specified

Medium: water

Support: none

Method 3

Type: Physical formation
Source:
Starting materials
  • siRNA against luciferase GL3
  • palmityl-stearyl-(C16-C18-)-modified PEG
  1. sPJt8tYzf0Xg
Product

PEI8.3-(C16-C18-EO25)1.4/siGL3 nanocomplex

Size: not specified

Medium: water

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial